Accrued and Other Current Liabilities - Additional Information (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Other Liabilities Current [Line Items]
Other current liabilities	$ 2,266,408		$ 2,621,611
Research and Development Agreement
Other Liabilities Current [Line Items]
Other current liabilities	2,200,000		$ 2,200,000
Research and Development Agreement | Other Income (Expense), Net
Other Liabilities Current [Line Items]
Repayable advance received	$ 2,200,000
Revenue recognized		$ 2,700,000